SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401914-23-000030
Filing Date
2023-06-21
Accepted
2023-06-21 21:41:31
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687398083.html 4  
1 FORM 4 wk-form4_1687398083.xml 4 4003
  Complete submission text file 0001401914-23-000030.txt   5592
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Kelley Susan L. (Reporting) CIK: 0001519612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 231031397